MENU

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies... Show more

Industry: #Biotechnology
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 14.51% to -64 cents per share on July 30

Replimune Group REPL Stock Earnings Reports
Q2'26
Est.
$-0.65
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.11
The last earnings report on June 29 showed earnings per share of -75 cents, missing the estimate of -68 cents. With 2.11M shares outstanding, the current market capitalization sits at 882.26M.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
479
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDESX42.70N/A
N/A
Fidelity Advisor Diversified Stock O
VIEIX180.71N/A
N/A
Vanguard Extended Market Index Instl
AGTIX152.23N/A
N/A
AB Sustainable Global Thematic I
MGFAX7.49N/A
N/A
MassMutual Global A
GMXRX16.57N/A
N/A
Nationwide Mid Cap Market Idx R

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+2.74%
IMNN - REPL
57%
Loosely correlated
-3.28%
SNDX - REPL
49%
Loosely correlated
-2.24%
KYMR - REPL
45%
Loosely correlated
-4.07%
NRIX - REPL
43%
Loosely correlated
-1.77%
ZYME - REPL
42%
Loosely correlated
-1.78%
More
Replimune Group (REPL) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com